/
LLC National Institute of Endocrinology
| GEL thousands | 2023 | 2024 | 2025 |
|---|---|---|---|
| P&L Items | |||
| Revenue | Register | 15,697 | Register |
| Adj. Operating Profit¹ | Register | 1,686 | Register |
| Adj. EBITDA¹ | Register | 2,492 | Register |
| Net Income | Register | 1,199 | Register |
| Margins & Profitability Ratios (%) | |||
| Adj. Operating Profit Margin¹ | Register | 10.7% | Register |
| Adj. EBITDA Margin¹ | Register | 15.9% | Register |
| Net Income Margin | Register | 7.6% | Register |
| Balance Sheet Items & Leverage | |||
| Total Assets | Register | 10,170 | Register |
| Total Debt² | Register | 2,180 | Register |
| Total Debt² / Adj. EBITDA¹ | Register | 0.87x | Register |
| Total Equity | Register | 7,207 | Register |
¹ Adj. Operating Profit has been adjusted to exclude non-recurring and one-time items. Adj. EBITDA is calculated by adding back D&A expenses to the adjusted operating profit.
² Total debt includes lease liabilities, where applicable.